UM

Browse/Search Results:  1-5 of 5 Help

Selected(0)Clear Items/Page:    Sort:
Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2 Journal article
Rao, Xia, Zhao, Runchu, Tong, Zhou, Guo, Shuxin, Peng, Weiyu, Liu, Kefang, Li, Shihua, Wu, Lili, Tong, Jianyu, Chai, Yan, Han, Pu, Wang, Feiran, Jia, Peng, Li, Zhaohui, Zhao, Xin, Li, Dedong, Zhang, Rong, Zhang, Xue, Zou, Weiwei, Li, Weiwei, Wang, Qihui, Gao, George Fu, Wu, Yan, Dai, Lianpan, Gao, Feng. Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2[J]. Proceedings of the National Academy of Sciences of the United States of America, 2023, 120(52), e2314193120.
Authors:  Rao, Xia;  Zhao, Runchu;  Tong, Zhou;  Guo, Shuxin;  Peng, Weiyu; et al.
Favorite | TC[WOS]:8 TC[Scopus]:9  IF:9.4/10.8 | Submit date:2024/01/02
Cryptic Epitope  Neutralizing Antibody  Omicron Ba.4/ba.5/bq.1.1/xbb Subvariant  Rbd-8  Sars-cov-2  
Dosing interval regimen shapes potency and breadth of antibody repertoire after vaccination of SARS-CoV-2 RBD protein subunit vaccine Journal article
Guo Shuxin, Zheng Yuxuan, Gao Zhengrong, Duan Minrun, Liu Sheng, Du Pan, Xu XiaoYu, Xu Kun, Zhao Xin, Chai Yan, Wang Peiyi, Zhao Qi, Gao George F., Dai Lianpan. Dosing interval regimen shapes potency and breadth of antibody repertoire after vaccination of SARS-CoV-2 RBD protein subunit vaccine[J]. Cell Discovery, 2023, 9(1), 79.
Authors:  Guo Shuxin;  Zheng Yuxuan;  Gao Zhengrong;  Duan Minrun;  Liu Sheng; et al.
Adobe PDF | Favorite | TC[WOS]:5 TC[Scopus]:5  IF:13.0/14.8 | Submit date:2023/08/25
Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2 Journal article
Xu, Kun, Gao, Ping, Liu, Sheng, Lu, Shuaiyao, Lei, Wenwen, Zheng, Tianyi, Liu, Xueyuan, Xie, Yufeng, Zhao, Zhennan, Guo, Shuxin, Tang, Cong, Yang, Yun, Yu, Wenhai, Wang, Junbin, Zhou, Yanan, Huang, Qing, Liu, Chuanyu, An, Yaling, Zhang, Rong, Han, Yuxuan, Duan, Minrun, Wang, Shaofeng, Yang, Chenxi, Wu, Changwei, Liu, Xiaoya, She, Guangbiao, Liu, Yan, Zhao, Xin, Xu, Ke, Qi, Jianxun, Wu, Guizhen, Peng, Xiaozhong, Dai, Lianpan, Wang, Peiyi, Gao, George F.. Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2[J]. Cell, 2022, 185(13), 2265-2278.e14.
Authors:  Xu, Kun;  Gao, Ping;  Liu, Sheng;  Lu, Shuaiyao;  Lei, Wenwen; et al.
Favorite | TC[WOS]:84 TC[Scopus]:88  IF:45.5/49.0 | Submit date:2022/08/02
Covid19 Vaccine  Delta Variant  Immunogen Structure  Omicron Variant  Rbd  Receptor-binding Domain  Sars-cov-2  Vaccine Protection  Variant Of Concern  Voc  
A Hemagglutinin Stem Vaccine Designed Rationally by AlphaFold2 Confers Broad Protection against Influenza B Infection Journal article
Zeng, Dian, Xin, Jiabao, Yang, Kunyu, Guo, Shuxin, Wang, Qian, Gao, Ying, Chen, Huiqing, Ge, Jiaqi, Lu, Zhen, Zhang, Limin, Chen, Junyu, Chen, Yixin, Xia, Ningshao. A Hemagglutinin Stem Vaccine Designed Rationally by AlphaFold2 Confers Broad Protection against Influenza B Infection[J]. Viruses, 2022, 14(6).
Authors:  Zeng, Dian;  Xin, Jiabao;  Yang, Kunyu;  Guo, Shuxin;  Wang, Qian; et al.
Favorite | TC[WOS]:5 TC[Scopus]:7  IF:3.8/4.0 | Submit date:2022/08/02
Influenza b Viruses (Ibv)  Stem Hemagglutinin (Ha)  Vaccine Design  Structure Prediction  Alphafold2  Broad Protection  
The genetic variant of sars-cov-2: Would it matter for controlling the devastating pandemic? Review article
2021
Authors:  Guo, Shuxin;  Liu, Kefang;  Zheng, Jun
Favorite | TC[WOS]:18 TC[Scopus]:23  IF:8.2/8.3 | Submit date:2022/05/13
501y.v2  Covid-19  D614g  Genetic Variant  Sars-cov-2  Voc 202012/01